Showing results (51-60 of 149) with videos related to
Sort By:
Pageof 15
Hypertension (Dallas, Tex. : 1979)|December 31, 2003
Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosisChun-Fang Xia, Hang Yin, Cesar V Borlongan, et al.Human Gene Therapy|February 3, 2005
Adrenomedullin gene delivery protects against cerebral ischemic injury by promoting astrocyte migration and survivalChun-Fang Xia, Hang Yin, Cesar V Borlongan, et al.Journal of Agricultural and Food Chemistry|February 13, 2009
Glycyrrhizin and licorice significantly affect the pharmacokinetics of methotrexate in ratsShiuan-Pey Lin, Shang-Yuan Tsai, Yu-Chi Hou, et al.Immunology|January 29, 2014
Human kallistatin administration reduces organ injury and improves survival in a mouse model of polymicrobial sepsisPengfei Li, Grant Bledsoe, Zhi-Rong Yang, et al.Human Gene Therapy|May 24, 2006
Reversal of renal fibrosis, inflammation, and glomerular hypertrophy by kallikrein gene deliveryGrant Bledsoe, Bo Shen, Yuyu Yao, et al.Plos One|May 26, 2017
Plasma kallistatin in critically ill patients with severe sepsis and septic shockWei-Chieh Lin, Chang-Wen Chen, Lee Chao, et al.Biological Chemistry|February 26, 2010
Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healingJulie Chao, Bo Shen, Lin Gao, et al.Experimental Cell Research|July 10, 2015
Kallistatin inhibits TGF-β-induced endothelial-mesenchymal transition by differential regulation of microRNA-21 and eNOS expressionYouming Guo, Pengfei Li, Grant Bledsoe, et al.Human Gene Therapy|November 4, 2006
Novel role of kallistatin in protection against myocardial ischemia-reperfusion injury by preventing apoptosis and inflammationJulie Chao, Hang Yin, Yu-Yu Yao, et al.Diabetes|April 28, 2005
Kallikrein gene delivery improves serum glucose and lipid profiles and cardiac function in streptozotocin-induced diabetic ratsDavid Montanari, Hang Yin, Eric Dobrzynski, et al.Pageof 15